-
September 07, 2012
Valeant makes a bold but logical bid for Medicis.
-
September 05, 2012
Valeant Pharmaceuticals International, Inc. (VRX) recently announced that it has entered into an agreement with ...
-
September 04, 2012
It's been a bad day for the market so far this morning. The Nasdaq has declined 0.8%; the S&P 500 is down 0.5%; and ...
-
September 04, 2012
The market is currently down, with the Nasdaq slipping 0.8%, the S&P 500 down 0.6% and the Dow declining 0.8%. The ...
-
August 15, 2012
The Nasdaq is trading up 0.2%, the S&P 500 has remained steady and the Dow remains relatively unchanged so far ...
-
August 14, 2012
The Nasdaq has climbed 0.6%, the S&P 500 is up 0.3% and the Dow has risen 0.3%, marking a bad morning for the ...
-
August 07, 2012
The market is having a good day so far: the Nasdaq has climbed 0.8%; the S&P 500 is up 0.7%; and the Dow has risen ...
-
August 06, 2012
Valeant Pharmaceuticals International's (VRX) second-quarter 2012 earnings of $1.02 per share (excluding special ...
-
July 17, 2012
The Nasdaq has slipped 0.1%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2% on a bad morning for the ...
-
July 13, 2012
The Nasdaq has climbed 0.5%, the S&P 500 is up 0.3% and the Dow has risen 0.5% on a good day for the market so far. ...
-
July 03, 2012
The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen ...
-
June 18, 2012
Valeant Pharmaceuticals International, Inc. (VRX) recently announced that it has entered into an agreement with ...
-
May 25, 2012
Here are four stocks that are sitting on important support and are high reward-to-risk buy candidates.
-
May 25, 2012
A year ago, Obagi Medical Products faced some problems in Texas that presented an investment opportunity. One year ...
-
March 08, 2012
A market pullback will create a buying opportuntiy for some of the top performing stocks.
-
January 18, 2012
Salix is a great candidate for growth investors.
-
December 29, 2011
2011 was a surprisingly healthy year for drug stocks.
-
November 10, 2011
With the majority of the developed world still facing problems, Canada is beacon of growth.
-
November 10, 2011
Medicis is well-run, but arguably too risky to stay independent.
-
August 03, 2011
Find out why Covidien is much better than many investors assume.
